Spinal Dural Arteriovenous Fistula International Data and Outcomes Registry

Conditions

• Spinal Dural Arteriovenous Fistula

Eligibility Criteria

Sex

ALL

Age

N/A - N/A

Healthy Volunteers

Not accepted

Study Details

Given the lack of large multicenter datasets in the context of Spinal arteriovenous fistula, the strength of the evidence surrounding this rare disease is limited. SPIDER hence aims to address that by compiling patient-level data from centers all around the world.

Key Dates

Start date

Jan 5, 2026

Status verified

May 2026

Primary completion

May 31, 2026

Completion

May 31, 2026

Study Design

Enrollment

1,000 participants (estimated)

Primary Outcome Measure

Treatment success [ Time Frame: Recorded at the end of the embolization or surgery. ]

Central Contacts

• Pascal Jabbour, MD
  215-955-7000
  [email protected]

Locations (1)

Find similar trials in Philadelphia, PA